|
Drugs and Chemicals of
Concern > Salvia Divinorum
SALVIA DIVINORUM AND SALVINORIN A
(Street Names: Maria Pastora, Sage of the
Seers,
Diviner’s Sage, Salvia, Sally-D, Magic Mint)
August 2007 DEA/OD/ODE
Introduction:
Salvia divinorum
is a perennial herb in the mint family native to certain areas of the Sierra
Mazateca region of Oaxaca, Mexico. The plant, which can grow to over 3 feet in
height, has large green leaves, hollow square stems and white flowers with
purple calyces, and can grow successfully outside of this region. Salvia
divinorum has been employed by the Mazatec Indians for its hallucinogen
effects for ritual divination and healing. The active constituent of Salvia
divinorum has been identified as salvinorin A. Currently, neither Salvia
divinorum nor any of its constituents, including salvinorin A, are
controlled under the federal Controlled Substances Act (CSA).
Licit Uses:
Neither Salvia divinorum or its
active constituent salvinorin A has an approved medical use in the U.S.
Chemistry and Pharmacology:
Salvinorin A, also called Divinorin A,
is believed to be the ingredient responsible for the hallucinogenic effects of
Salvia divinorum. Chemically, it is a neoclerodane diterpene found
primarily in the leaves, and to a lesser extent in the stems. Although several
other substances have been isolated from the plant, none have been shown to be
psychoactive.
In the U.S., plant material is typically
either chewed or smoked. When chewed, the leaf mass and juice are maintained
within the cheek area with absorption occurring across the lining of the oral
mucosa (buccal). Effects first appear within 5 to 10 minutes. Dried leaves, as
well as extract-enhanced leaves purported to be enriched with salvinorin A,
are also smoked. Smoking pure salvinorin A, at a dose of 200-500 micrograms,
results in effects within 30 seconds and lasts about 30 minutes.
A limited number of studies have
reported the effects of using either plant material or salvinorin A. Psychic
effects include perceptions of bright lights, vivid colors and shapes, as well
as body movements and body or object distortions. Other effects include
dysphoria, uncontrolled laughter, a sense of loss of body, overlapping
realities, and hallucinations (seeing objects that are not present). Adverse
physical effects may include incoordination, dizziness, and slurred speech.
Scientific studies show that salvinorin
A is a potent and selective kappa opioid receptor agonist. Other drugs that
act at the kappa opioid receptor also produce hallucinogenic effects and
dysphoria similar to that produced by salvinorin A. Salvinorin A does not
activate the serotonin 2A receptor, which mediates the effects of other
schedule I hallucinogens.
Illicit Uses:
Salvinorin A and Salvia
divinorum products are abused for their ability to evoke hallucinogenic
effects, which, in general, are similar to those of other scheduled
hallucinogenic substances, including LSD, DMT, psilocybin, and ketamine.
User Population:
Information on the user population is
limited. It appears to be mostly adolescents and younger adults influenced by
promotions of the drug on Internet sites.
Illicit Distribution:
Salvia divinorum
is grown domestically and imported from Mexico and Central and South America.
The Internet is an important venue for the promotion and distribution of Salvia
divinorum. It is sold as seeds, plant cuttings, whole plants, fresh and
dried leaves, extract-enhanced leaves of various strengths (e.g., 5x, 10x,
20x, 30x), and liquid extracts purported to contain salvinorin A. These
products are also sold at local retail shops (e.g., head shops and tobacco
shops).
Control Status:
Salvia divinorum
and salvinorin A are not currently controlled under the CSA. However, a number
of states have placed controls on Salvia divinorum and/or salvinorin A.
In 2005, Louisiana made it illegal to purchase or distribute Salvia
divinorum. Both Delaware and Missouri have added Salvia divinorum
and salvinorin A into schedule I of the states’ drug regulations. In 2006,
Tennessee and Oklahoma passed legislation on Salvia divinorum. Maine
and North Dakota have also recently passed legislation controlling Salvia
divinorum and/or salvinorin. Moreover, as of July 2007, legislative bills
proposing regulatory controls on salvinorin A and/or Salvia divinorum
are pending in Alabama, Alaska, California, Florida, Illinois, Iowa, New
Jersey, New York, Ohio, Oregon, Pennsylvania, and Texas. Internationally,
salvinorin A and/or Salvia divinorum have been placed under regulatory
controls in Australia, Belgium, Denmark, Estonia, Finland, Italy, Spain, and
Sweden.
Comments and additional information are welcomed by the
Drug and Chemical Evaluation Section, FAX 202-353-1263 or telephone
202-307-7183.
|